Milpitas, CA, United States of America

Satoshi Ohtake

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Chesterfield, MO (US) (2015)
  • Milpitas, CA (US) (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Satoshi Ohtake

Introduction

Satoshi Ohtake is a prominent inventor based in Milpitas, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of infectious diseases. With a total of six patents to his name, Ohtake's work is recognized for its innovative approaches to complex medical challenges.

Latest Patents

Ohtake's latest patents include a groundbreaking formulation utilizing gallium for the treatment and prevention of infectious diseases. This method and composition target bacterial infections caused by both gram-negative and gram-positive bacteria, including multidrug-resistant strains. His second recent patent focuses on highly dispersible powders, detailing a method for selecting pharmaceutically acceptable excipients that facilitate the production of these powders through spray drying.

Career Highlights

Ohtake is currently associated with Aridis Pharmaceuticals, where he continues to advance his research and development efforts. His work has been instrumental in creating effective solutions for challenging medical conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Ohtake collaborates with talented professionals in his field, including Vu Truong-Le and Luisa Yee. These partnerships enhance the innovative potential of his projects and contribute to the overall success of their endeavors.

Conclusion

Satoshi Ohtake's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in addressing critical health issues. His patents reflect a commitment to advancing medical science and improving treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…